TickerFacts.

Baird Medical Investment Holdings Ltd (BDMD): Cost of Revenue

Annual figures by period end, from SEC filings.

$3.65M
Year ended 2025-12-31
-19.7%
3-year compound annual growth
$7.05M2022-12-31: $7.05M2023-12-31: $4.23M2024-12-31: $4.38M2025-12-31: $3.65M$3.65M
2022-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$3.65M-16.7%2026-07-27, From 2025-01-01
2024-12-31$4.38M+3.7%2026-07-27, From 2024-01-01
2023-12-31$4.23M-40.1%2026-07-27, From 2023-01-01
2022-12-31$7.05Mn/a2025-05-15, From 2022-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$3.65M-16.7%
DarioHealth Corp. (DRIO)2025-12-31$9.69M-29.6%
Spectral AI, Inc. (MDAI)2025-12-31$10.72M-34.2%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$12.11M+37.3%
Nephros Inc (NEPH)2025-12-31$7.16M+31.7%
Sensus Healthcare, Inc. (SRTS)2025-12-31$15.62M-10.1%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$6.90M+14.8%
Profound Medical Corp. (PROF)2025-12-31$4.71M+29.2%
Biotricity Inc. (BTCY)2026-03-31$3.05M-5.5%

Compare BDMD, DRIO, MDAI, SNOA side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗